Suppr超能文献

具有特定错配修复基因缺陷的人类癌细胞系中次黄嘌呤磷酸核糖转移酶(hprt)基因座的突变率。

Mutation rate at the hprt locus in human cancer cell lines with specific mismatch repair-gene defects.

作者信息

Glaab W E, Tindall K R

机构信息

Curriculum in Toxicology, University of North Carolina, Chapel Hill 27599, USA.

出版信息

Carcinogenesis. 1997 Jan;18(1):1-8. doi: 10.1093/carcin/18.1.1.

Abstract

Spontaneous mutation rates at the hypoxanthine-guanine phosphoribosyl transferase (hprt) locus were measured in human cancer cell lines defective in the mismatch repair (MMR) genes hMLH1, hPMS2, or GTBP, as well as in a cell line carrying mutations in both hMLH1 and hPMS2. The mutation rate was determined by quantitating mutant frequency increases within a single culture as a function of cell division. These MMR-deficient cell lines exhibited a 50- to 750-fold increase in mutation rate relative to a MMR-proficient cancer cell line. From lowest to highest, the spontaneous mutation rates relative to the MMR-gene defects studied here are as follows: hMLH1- < GTBP- < hPMS2- < hMLH1- / hPMS2-. In addition, a cell line in which MMR was restored by chromosome transfer exhibited a mutation rate 12-fold below the MMR-deficient parental cell line. These data support the notion that MMR plays an important role in controlling the rate of spontaneous mutation and suggest that different MMR-gene defects may vary in their ability to repair different types of DNA mismatches, thus leading to measurable quantitative differences in spontaneous mutagenesis. Furthermore, a difference in mutation rates was observed between a hPMS2-defective cell line (3.1 x 10(-5) mutations/cell/generation) and two hMLH1-defective cell lines (4.0 x 10(-6) and 7.3 x 10(-6) mutations/cell/generation). Assuming the hPMS2- and hMLH1-gene products only function in the proposed hMutL alpha heterodimer, then defects in either gene should yield comparable mutation rates. These data suggest that hPMS2 plays a critical role in MMR, while additional hMLH1 homologues or hPMS2 alone may function to partially complement defects in hMLH1.

摘要

在错配修复(MMR)基因hMLH1、hPMS2或GTBP存在缺陷的人类癌细胞系,以及同时携带hMLH1和hPMS2突变的细胞系中,测量了次黄嘌呤 - 鸟嘌呤磷酸核糖转移酶(hprt)位点的自发突变率。通过定量单个培养物中突变频率随细胞分裂的增加来确定突变率。相对于具有MMR功能的癌细胞系,这些MMR缺陷的细胞系的突变率增加了50至750倍。从最低到最高,相对于此处研究的MMR基因缺陷,自发突变率如下:hMLH1缺陷型 < GTBP缺陷型 < hPMS2缺陷型 < hMLH1 / hPMS2双缺陷型。此外,通过染色体转移恢复MMR功能的细胞系的突变率比MMR缺陷的亲代细胞系低12倍。这些数据支持了MMR在控制自发突变率中起重要作用的观点,并表明不同的MMR基因缺陷在修复不同类型DNA错配的能力上可能存在差异,从而导致自发诱变中可测量的定量差异。此外,在一个hPMS2缺陷的细胞系(3.1×10⁻⁵个突变/细胞/代)和两个hMLH1缺陷的细胞系(4.0×10⁻⁶和7.3×10⁻⁶个突变/细胞/代)之间观察到了突变率的差异。假设hPMS2和hMLH1基因产物仅在所提出的hMutLα异源二聚体中起作用,那么任一基因的缺陷都应产生相当的突变率。这些数据表明hPMS2在MMR中起关键作用,而额外的hMLH1同源物或单独的hPMS2可能起到部分弥补hMLH1缺陷的作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验